PLIVA 393 (Benztropine 0.5 mg )
Pill imprint PLIVA 393 has been identified as Benztropine mesylate 0.5 mg .
Benztropine is used in the treatment of extrapyramidal reaction; parkinson's disease; hyperhidrosis and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- PLIVA 393
- Strength:
- 0.5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pliva Inc.
More about benztropine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 12 Reviews – Add your own review/rating
- Drug class: anticholinergic antiparkinson agents
Consumer resources
- Benztropine
- Benztropine tablets
- Benztropine (Advanced Reading)
- Benztropine Injection (Advanced Reading)
Other brands: Cogentin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
